A clinical study to assess how the time of consumption of anti-hypertensive medication affects the BP of patients of primary hypertension.

A randomized open-label clinical study of the role of time of administration on the effect of once-daily administered anti-hypertensive medication in Primary Hypertension. - NIL

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/11/060317

Enrollment

320

Registered

2023-11-29

Start date

Unknown

Completion date

Unknown

Last updated

2023-12-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I10- Essential (primary) hypertension

Interventions

Intervention1: Anti-hypertensive drug (Tablet): Dose : as per drug and physicians discretion Frequency : once-daily (morning) Duration : 3 months Control Intervention1: Anti-hypertensive drug (Tablet)

Eligibility

Inclusion criteria

Inclusion criteria: 1. Newly diagnosed cases of primary hypertension who have been prescribed once-daily dose of any anti-hypertensive drug, as per discretion of treating physician. 2. Known cases of hypertension who require addition of another anti-hypertensive in once daily dosing.

Exclusion criteria

Exclusion criteria: 1.Pregnant women. 2.Patients with Secondary Hypertension. 3.Patients in whom principal investigator is not allowed to randomize the dosing by the treating physician.

Design outcomes

Primary

Measure	Time frame
Change in BP valuesTimepoint: 3 months	—

Secondary

Measure	Time frame
Change in adverse effect profileTimepoint: 3 months	—

Countries

India

Contacts

Public ContactDr Ashiya Parveen

B.J. Govt. Medical College, Pune

daswani_bharti@rediffmail.com7058687486

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026